A generated negative reversal week, having gone above the previous week's high and then making a new 29-week intraweek and weekly closing low. The stock closed on the low of the week and further downside below last week's low at 116.36 is expected to be seen this week. There is decent to perhaps even strong intraweek support between 112.52 and 113.28 (112.71-115.79 on a weekly closing basis) that should be seen but not broken, unless the market outlook is for even lower prices. A weekly close next Friday below 112.71, would suggest a drop down to 102.77 would be seen. On a monthly closing basis (Monday), the 118.77 level is support. Any daily close above 123.10 would take away ammunition from the bears.

BCTX generated a negative reversal week, having made a new 5-week intraweek high and then closing red and near the low of the week, suggesting further downside below last week's low at 3.77 will be seen this week. The break above the 60-minute MA seen the previous week, was negated, meaning that the bulls lost whatever slight edge they may have obtained. The MA line is at 4.00, meaning that if the bulls can get above the line, stay above the line for at least 2 hours, and confirm that with a rally above 4.36, the bulls will gain the edge back. Otherwise, there is no support below until 3.35 is reached. That support is decent.

BTZI generated a negative reversal week, having gone above and below the previous week's trading range, and closing red and in the lower half of the week's trading range, suggesting further downside below last week's low at .003 will be seen this week. The stock did close at a pivotal daily and weekly closing level at .004, meaning that the closes this entire week will be indicative. A rally above last week's high at .007 would negate the action seen this past week.

FSLR generated a new 43-month intraweek and weekly closing low and closed near the low of the week, suggesting further downside below last week's low at 124.32 will be seen this week. There is one remaining intraweek support at 115.65 (118.28 on a daily closing basis and 122.60 on a weekly closing basis) that is indicative and pivotal. There has been no negative news to support this weakness. In fact, on Friday, Jefferies raised his buy rating objective from $201 to $202. In addition, the company announced there were supporting their U.S. based facilities for building Solar panels. Daily close resistance is now found at 131.46. A daily close above that level would give the bulls the short-term edge.

LXRX signed a pact agreement with Novo Nordisk for its obesity drug, which is worth $1 billion dollars. On the news, the stock rallied 75% in value (from the previous weekly close to last week's intraweek high) and closed 58% higher. The news and the action does suggest that a bottom has been found. Nonetheless, the bulls have to do more before that becomes a reality, given that they need to generate a daily close above .65 cents (closed at .57 with an intraweek high at .70) for it to become a tangible statement of a bottom. A close above .784 would generate a buy signal and a close above 1.00 would be a game-changer in favor of the bulls. Any daily close below .39 would give control back to the bears. This was a fundamentally based rally, suggesting that the gap up at .35 will likely be followed with another gap up, likely to be seen this coming week (probably after Wednesday's announcement of the Tariffs.

PRAA generated a green week but then closed near the low of the week, suggesting further downside below last week's low at 20.25 will be seen this week. The recent multi-week low at 18.00 has not yet gotten the needed/required retest of it, suggesting that is what will be happening this week. The 19.60 level represents important and pivotal support and is a likely target for this week. If that holds up and then stock gets above last week's high 21.33 the following week, it will see new buying interest. Any close below 19.60 would be a negative.

VWDRY gapped down this past week and closed on the low of the week, suggesting further downside below last week's low at 4.72, will be seen this week. There was no news to support the gap, and as such, this move down is likely temporary. The stock already shows 3 previous successful retests of the 4.19 low and this will likely end up being the 4th. The last retest was at 4.46 and as such, that level should not be broken. The stock did close on Friday $.05 below the daily close breakout level at 4.80, and as such, it is likely that it will move below 4.72 on Monday but close green. A daily close above 5.14 should bring the buyers back.

ZLAB generated an outside week, having gone below last week's low and then above last week's high and closing green and in the upper half of the week's trading range, suggesting further upside above last week's high at 39.77 will be seen this week. The company announced this past week that it will be presenting new data for their cancer drug at the American Association for Cancer Research meeting on April 25th- 30th. With the new multi-month intraweek high and the news, it is now likely that the stock will get up to the 200-week MA, currently at 44.59, before the meeting occurs. The only possible stumbling block is Trump's tariffs. Nonetheless and unless Trump raises them above what has already been announced, it is not likely to be a negative. A drop below last week's low at 33.33 will be a negative. A daily close above 38.35 would be a stimulant for the move to the MA line.